| EPITOPE SUMMARY | |
|---|---|
| SLLQHLIGL is a linear peptidic epitope (epitope ID ) studied as part of Melanoma antigen preferentially expressed in tumors (UniProt:P78395) from Homo sapiens (human). This epitope has been studied for immune reactivity in publication(s), tested in T cell assays and MHC ligand assays. | |
| CURATED EXPERIMENTAL DATA | |
|---|---|
MHC Ligand Assay(s) | |
| MHC molecule | Positive / All |
| HLA class II | / |
| HLA-A*02:01 | / |
| HLA class I | / |
| HLA-DRB1*15:01 | / |
| HLA-A*32:01 | / |
| HLA-A2 | / |
| HLA-B*08:01 | / |
| HLA-C*05:01 | / |
| HLA-C*14:02 | / |
| HLA-DRB5*01:01 | / |
| HLA-E*01:03 | / |
T Cell Assay(s) | |
| Assay Type | Positive / All |
| qualitative binding | / |
| IFNg release | / |
| EXTERNAL RESOURCES | |
|---|---|
| Resource | Link |